From Invisibility to Inclusion: Evidence, Lived Experience, and Policy Directions for Multiple Chemical Sensitivity Report from the Resilience 2025 International Conference. [PDF]
Vangala K +3 more
europepmc +1 more source
When ESG Becomes Value: Stock Market Rewards of Sustainable Banking in Europe
ABSTRACT This study examines the relationship between sustainable investing and stock performance in the European banking sector. Specifically, it investigates the impact of the overall ESG score as well as the individual ESG pillars on stock performance, with particular attention to differences across high‐capital‐buffer and large‐sized banks.
Antoine B. Awad
wiley +1 more source
How do medical institutions co-create artificial intelligence solutions with commercial startups? [PDF]
Grootjans W +2 more
europepmc +1 more source
ABSTRACT ESG practices offer various benefits for family firms; however, there has been limited focus on how these practices can specifically advantage the owning family. To address this gap, we conduct a multiple‐case study of six Italian family firms.
Rafaela Gjergji +4 more
wiley +1 more source
Transforming the American Academy of Microbiology for social good through scientific portfolios. [PDF]
Nguyen NK +5 more
europepmc +1 more source
ABSTRACT This study examines the relationship between board independence and corporate social responsibility (CSR) outcomes. Based on legitimacy theory, we conducted a structured literature review of 167 archival studies to analyze the influence of board independence on CSR performance and reporting.
Patrick Velte
wiley +1 more source
Evaluating the Role of Machine Learning and Artificial Intelligence in Oncology Drug Repurposing Efforts. [PDF]
Mann A.
europepmc +1 more source
Seats at the Table, Shifts in the Actions: Board Gender Diversity and Climate Activism
ABSTRACT As regulatory and stakeholder pressures intensify, firms are increasingly expected to move beyond symbolic sustainability commitments towards corporate climate activism. This concept refers to the active institutionalisation of climate‐focused mechanisms such as external assurance, board oversight and climate‐linked incentives.
Md Tanvir Hamim, Rasim Simsek
wiley +1 more source
A father's crusade in rare disease drug development: a case study of Elpida therapeutics and Melpida. [PDF]
Portero D, Xu Q, Hussain A, Lo AW.
europepmc +1 more source
ABSTRACT This study investigates how internal governance design supports credible ESG performance by distinguishing between Incentive and Oversight Architectures. Using 13,993 firm‐year observations of US nonfinancial firms from 2018 to 2024, we estimate fixed effects and two‐step system GMM models.
Beyza Gürel +2 more
wiley +1 more source

